These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10371752)

  • 41. Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure.
    Monga M; Macias B; Groppo E; Kostelec M; Hargens A
    J Urol; 2006 Jul; 176(1):127-31. PubMed ID: 16753386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxalate and phytate of soy foods.
    Al-Wahsh IA; Horner HT; Palmer RG; Reddy MB; Massey LK
    J Agric Food Chem; 2005 Jul; 53(14):5670-4. PubMed ID: 15998131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
    Siener R; Jahnen A; Hesse A
    Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary Tamm-Horsfall protein and citrate: a case-control study of inhibitors and promoters of calcium stone formation.
    Pourmand G; Nasseh H; Sarrafnejad A; Mehrsai A; Hamidi Alamdari D; Nourijelyani K; Shekarpour L
    Urol J; 2005; 2(2):79-85. PubMed ID: 17629875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 2001 Mar; 101(3):326-31. PubMed ID: 11269613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lithogenic risk factors for renal stones in patients with Crohn's disease.
    Buño Soto A; Torres Jiménez R; Olveira A; Fernández-Blanco Herraiz I; Montero García A; Mateos Antón F
    Arch Esp Urol; 2001 Apr; 54(3):282-92. PubMed ID: 11432047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Predictive value of lithogenic risk in hypercalciuria: should 24-hour urine calcium be measured?].
    Ulmann A
    Nephrologie; 1984; 5(5):232-4. PubMed ID: 6531063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metabolic investigation of calcium oxalate urinary lithiasis. Indicators of lithogenic risk: modalities, applications and perspectives].
    Robert M
    Prog Urol; 1996 Feb; 6(1):44-51. PubMed ID: 8624527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Granulated potassium citrate in the prevention of calcium oxalate lithiasis].
    Campoy Martínez P; Arrabal Martín M; Quintero Rodríguez R; Espinosa Olmedo FJ; Castillo Gómez J; García Pérez M
    Actas Urol Esp; 1994 Feb; 18(2):101-5. PubMed ID: 7976691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Physiopathology of idiopathic calcium lithiasis].
    Bataille P; Fournier A; el Esper N; Westeel PF
    Nephrologie; 1990; 11(1):29-42. PubMed ID: 2197570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Citrate and renal calculi.
    Pak CY
    Miner Electrolyte Metab; 1987; 13(4):257-66. PubMed ID: 3306318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring the Potential Relationship Between Phytate Ingestion, Urinary Phytate Excretion, and Renal Stone Risk in a Unique Human Model: No Hard Evidence in Support of Phytate as a Stone Inhibitor.
    Fakier S; Rodgers A
    J Ren Nutr; 2020 Sep; 30(5):396-403. PubMed ID: 31928801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of potassium phytate effects on decreasing urinary calcium in rats.
    Grases F; Perelló J; Simonet BM; Prieto RM; García-Raja A
    Urol Int; 2004; 72(3):237-43. PubMed ID: 15084770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.